Clinical trial
Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
NCT00255229 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00255229 |
|---|---|
| Title | Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea |
| Official title | Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Cross Cancer Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug, Other |
| Interventions | Glutamine, Placebo |
| Enrollment | 130 |
| Start date | Dec 1, 2002 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Nov 18, 2005 |
| Last update posted | Feb 25, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: